S.Res. 770

119 SRES 770 ATS: Designating June 6, 2026, as National Naloxone Awareness Day.
 U.S. Senate
 2026-06-15
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 III  119th CONGRESS  2d Session  S. RES. 770  IN THE SENATE OF THE UNITED STATES   June 15, 2026   Mr. Scott of Florida  (for himself,  Mr. Markey ,  Ms. Cantwell ,  Mr. Tillis ,  Mr. Blumenthal ,  Mrs. Capito ,  Mr. Whitehouse ,  Ms. Klobuchar ,  Mr. Risch ,  Mr. King ,  Mr. Heinrich ,  Mr. Wyden ,  Mr. Booker ,  Mr. Bennet ,  Mr. Lankford ,  Mrs. Moody ,  Mr. Justice , and  Ms. Cortez Masto ) submitted the following resolution; which was considered and agreed to   RESOLUTION
Designating June 6, 2026, as National Naloxone Awareness Day.
Whereas opioid overdoses continue to devastate communities across the United States, leading to a significant loss of life and widespread societal impact;
Whereas opioid overdoses during the 12 months preceding November of 2025 claimed a reported 43,810 lives in the United States;
Whereas fatal overdoses are often witnessed by a bystander;
Whereas, in 2025 alone, the Drug Enforcement Administration seized more than 369,000,000 potentially deadly doses of fentanyl, enough to kill every individual in the United States;
Whereas, according to data from the Centers for Disease Control and Prevention, fentanyl-related poisonings are a leading cause of death for individuals in the United States between 18 and 44 years of age;
Whereas naloxone is a safe and effective medication that can reverse opioid overdoses and save lives when administered promptly by rapidly reversing the effects of opioids;
Whereas naloxone plays a vital role in preventing long-term brain damage and reducing the risk of fatality associated with opioid overdoses;
Whereas the Centers for Disease Control and Prevention recognizes naloxone as an important tool in preventing opioid overdose deaths;
Whereas it is imperative to educate individuals, families, healthcare professionals, and first responders about—
(1)
the benefits of naloxone, including the potential naloxone has to reduce opioid-related fatalities; and
(2)
how to safely administer naloxone;
Whereas it is imperative to identify current or potential barriers for individuals, organizations, and Federal, State, and local governments to obtain and distribute naloxone;
Whereas increasing access to naloxone can improve the chances of recovery for individuals struggling with opioid use disorder and support a future free from the grip of opioid use disorder;
Whereas the Food and Drug Administration acted to authorize the over-the-counter sale of 10 milligram doses of naloxone alongside extending the shelf life of newly manufactured naloxone 4 milligram nasal spray products from 3 to 4 years in 2024; and
Whereas recognizing National Naloxone Awareness Day will contribute to the ongoing efforts to educate the public, reduce the stigma associated with substance use disorder, and promote access to lifesaving naloxone: Now, therefore, be it
That the Senate—
(1)
designates June 6, 2026, as National Naloxone Awareness Day;
(2)
recognizes the life-saving benefits of naloxone in reversing opioid overdoses and preventing unnecessary deaths;
(3)
acknowledges that increased access to naloxone empowers individuals, families, healthcare professionals, and first responders to intervene in emergency situations and provide immediate assistance to those experiencing an opioid overdose;
(4)
recognizes that National Naloxone Awareness Day serves as an opportunity to educate the public about the importance of recognizing the signs of opioid overdose and equipping themselves with naloxone to save lives;
(5)
encourages Federal, State, and local governments, as well as private and nonprofit organizations, to support increased naloxone access, education, and distribution efforts; and
(6)
calls upon Federal agencies, including the Substance Abuse and Mental Health Services Administration, the Centers for Disease Control and Prevention, the Office of National Drug Control Policy, the Drug Enforcement Administration, and all others engaged in the National Drug Control Strategy to continue supporting public awareness of naloxone, and overdose and poisoning prevention.